FRANCES FLIT: Open Payments
NPI 1609629799 · ENCINO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$285 in 13 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $106 · 2025 $285
Food & beverage: $285
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $62 |
| Merck Sharp & Dohme LLC | 3 | $59 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| Lilly USA, LLC | 1 | $30 |
| Exact Sciences Corporation | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| Corcept Therapeutics | 1 | $23 |
| Novo Nordisk Inc | 1 | $19 |
Products named: CAPVAXIVE, JARDIANCE, SHINGRIX, MOUNJARO, TRELEGY ELLIPTA, Cologuard Collection Kit, AIRSUPRA, Korlym.
Industry payments across CA — which companies pay providers there.
